Searched for
ELI LILLY AGREEMENT
Dow Jones hits record above 52,000 as Alphabet debuts in index, S&P 500 climbs and Nasdaq jumps over 2% as tech stocks lead Wall Street rally - here's how US stock market performed today (June 29)S&P 500, Dow Jones and Nasdaq today June 29: The US stock market started the shortened trading week with solid gains as the Dow Jones close...- US stocks: Musk's SpaceX prices record $75 billion IPO at $135 a shareSpaceX has priced its record-breaking U.S. IPO at $135 per share, raising $75 billion and valuing the company at $1.77 trillion. This makes...
- Novartis experimental actinium-based drug shows promise in prostate cancer treatment: StudyNovartis' new experimental actinium-based drug shows promise against prostate cancer. Early data on Sunday revealed anti-tumour activity, e...
- Molecule glue drugs shake up cancer care, draw big moneyHarvard-born idea doubles survival in trials, triggers pharma frenzy as cos race to target 'undruggable' proteins with next-gen glue therap...
- US stocks today: S&P 500 and Nasdaq hit record closing highs as US and Iran agree to extend ceasefireThe S&P 500 and Nasdaq hit record closing highs as hopes of a US Iran ceasefire extension boosted sentiment. Investors also digested US inf...
- Zydus Lifesciences acquires US pharma firm Assertio for $166 millionIn a bold move that positions Zydus at the forefront of the U.S. specialty oncology market, the Indian drug manufacturer has secured a $166...
- Google’s Isomorphic Labs to raise over $2 billion in new fundingAlphabet's AI drug discovery firm, Isomorphic Labs, is reportedly close to securing over $2 billion in new funding, led by Thrive Capital. ...
- Mounjaro maker signs $2.7 billion deal on AI drug researchThe new deal builds on existing collaborations between the two companies, which struck a software licensing agreement in 2023, according to...
- Bajaj Healthcare moves Indian patent office for compulsory licence for Covid drugEli Lilly & Company declined the applications on both the occasion, citing the reason that it is really challenging for them to sign volunt...
- BDR Pharma inks licensing pact with Eli Lilly for COVID-19 treatment drugBaricitinib has received restricted emergency use approval, for use in combination with Remdesivir, for treatment of suspected or laborator...
- Eli Lilly inks pacts for COVID-19 drug Baricitinib with Torrent Pharma, Dr Reddy's, MSN LabsThe company has issued additional royalty-free, non-exclusive voluntary licences to Dr Reddy's, MSN Laboratories and Torrent Pharmaceutical...
- Dr Reddy's inks licensing pact with Eli Lilly for COVID-19 treatment drugThe Hyderabad-based firm said it has entered into a royalty-free, non-exclusive voluntary licensing agreement with Eli Lilly and Company fo...
- Lupin partners Eli Lilly to market diabetes drug 'Eglucent'According to the agreement, Lupin will market and sell Eglucent through its own specialty field force while Lilly will be responsible for m...
- Strides Arcolab inks pact with Eli Lilly for cancer drugsAgila Specialties will manufacture the cancer medicines, and Lilly will register and market them in geographies across the emerging markets...
- Jubilant extends collaboration with Eli LillyPharma company Jubilant Organosys has extended its four-year-old drug research collaboration with Eli Lilly for another five years.
- Zydus eyes $ 300 million revenue generation with Eli LillyZydus Cadila eyes large chunk of revenue generation from its new drug discovery pact with global drug giant Eli Lilly.
- Glenmark, Eli Lilly suspend drug development; stock down 20%Shares of Glenmark Pharma plunged 20 per cent after it announced that its partner Eli Lilly has suspended further clinical development for ...
- Eli Lilly pops patent pep pill, to launch latest drugsEncouraged by the introduction of the product patent regime, US-based Eli Lilly & Company is planning to introduce a range of new drugs in ...
- NPIL to develop, mkt US-based Eli Lilly productsPharma major Nicholas Piramal India Ltd (NPIL) will develop and commercialise a select group of US-based Eli Lilly and Company's pre-clinic...
- Suven ties up with US-based pharma coSuven Life Sciences Ltd has signed an agreement with US-based pharmaceutical firm Eli Lilly and Company to carryout pre-clinical research f...
Load More
